FBT vs FTXH

Side by side

	FBT	FTXH
Fund	First Trust NYSE Arca Biotechnology Index Fund	First Trust Nasdaq Pharmaceuticals ETF
Issuer	First Trust	First Trust
Category	Biotech & Health Innovation	Health Care
Expense ratio	0.55%	0.60%
Assets	$2.9B	$1.1B
Average daily dollar volume	$20M	$10M
Listed	Jun 19, 2006	Sep 20, 2016
FrenzyCap score	67	51
1-month return	+1.2%	+1.8%
3-month return	+7.2%	+7.9%
Year to date	+28.5%	+25.3%
1-year return	+41.3%	+40.7%
30-day volatility	21.4%	15.2%
Worst drawdown, 1 year	−14.3%	−7.5%
Trailing 12-month yield	—	0.70%
Holdings	32	51
Top 10 weight	43.2%	53.1%
Look-through P/E	62.4	43.5
Holdings vs fair value	+7.1%	+7.5%
Holdings above 200-day average	73%	83%
Net flow, latest 3 reported months	+$2.5M thru Jun 2026	+$3.3M thru Jun 2026
30-day implied volatility	24.8%	37.9%
Holdings as of	as of Jun 30, 2026SEC filing	as of Jun 30, 2026SEC filing

Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.

Largest shared holdings

50% of FBT · 32% of FTXH

Holding	FBT	FTXH
BIIB	3.37%	3.84%
VRTX	3.07%	3.41%
AMGN	2.78%	3.18%
UTHR	2.56%	2.72%
GILD	2.45%	2.89%
INCY	3.18%	2.39%
REGN	2.25%	2.72%
ILMN	3.92%	1.98%
EXEL	3.32%	1.73%
NBIX	3.53%	1.37%
ALKERMES PLC	4.24%	1.35%
HALO	3.11%	1.21%
BMRN	2.83%	1.11%
ARWR	3.38%	0.66%
KRYS	3.87%	0.63%
ALNY	2.52%	0.42%

Sector mix of the stock holdings

Sector	FBT	FTXH	Gap
Health Care	82.4%	92.7%	−10.3%
Technology	8.2%	2.8%	+5.5%
Industrials	5.1%	0.0%	+5.1%

More: full overlap table · FBT holdings · FTXH holdings

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.